A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is ...

A new study published in the journal of Eye showed that in some ethnic groups like the non-Hispanic Whites and ...

The global Retinal Vein Occlusion (RVO) treatment market was valued at approximately USD 2.65 billion in 2023 and is projected to exhibit a compound annual growth rate (CAGR) of 6.92% over the ...

Advanced mechanical design to address both subacute, organized thrombus and more dense, fibrotic tissue; devices with a low ...

Harrow has entered into an agreement with Samsung Bioepis for the U.S. commercial rights to two ophthalmology biosimilars, ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Samsung Bioepis Co., Ltd. ("Samsung Bioepis") announced today that the company has entered into a license, development and ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it has entered into a ...

It’s always said that the eyes are a window to the soul, but science now suggests they might also be a window to the heart.

A discussion on pathophysiology, patient workup, gaps in data and disease-specific tools, and postprocedural follow-up and ...

To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ...